Diagnosis and treatment of neurocysticercosis.

PubWeight™: 2.20‹?› | Rank: Top 2%

🔗 View Article (PMC 3350327)

Published in Nat Rev Neurol on September 13, 2011

Authors

Theodore E Nash1, Hector H Garcia

Author Affiliations

1: Gastrointestinal Parasites Section, Laboratory of Parasitic Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Associated clinical trials:

Treatment of Patients With Cysticercosis With Praziquantel or Albendazole | NCT00001205

People Presenting With Neurocysticercosis in North America | NCT02233855

Articles citing this

Neurocysticercosis: A natural human model of epileptogenesis. Epilepsia (2014) 2.11

Human infection with marten tapeworm. Emerg Infect Dis (2013) 1.13

A review on diagnostic and preventive aspects of cystic echinococcosis and human cysticercosis. Trop Parasitol (2012) 1.10

Neurocysticercosis in sub-Saharan Africa: a review of prevalence, clinical characteristics, diagnosis, and management. Pathog Glob Health (2012) 1.06

Edema surrounding calcified intracranial cysticerci: clinical manifestations, natural history, and treatment. Pathog Glob Health (2012) 1.03

Neurocysticercosis in the United States. Pathog Glob Health (2012) 0.98

Intraventricular Taenia solium cysts presenting with Bruns syndrome and indications for emergent neurosurgery. Am J Trop Med Hyg (2015) 0.96

On the relationship between neurocysticercosis and mesial temporal lobe epilepsy associated with hippocampal sclerosis: coincidence or a pathogenic relationship? Pathog Glob Health (2012) 0.95

Neurocysticercosis-more than a neglected disease. PLoS Negl Trop Dis (2013) 0.93

Added value of antigen ELISA in the diagnosis of neurocysticercosis in resource poor settings. PLoS Negl Trop Dis (2012) 0.92

Regulation of the host immune system by helminth parasites. J Allergy Clin Immunol (2016) 0.91

Corticosteroid withdrawal precipitates perilesional edema around calcified Taenia solium cysts. Am J Trop Med Hyg (2013) 0.90

PET reveals inflammation around calcified Taenia solium granulomas with perilesional edema. PLoS One (2013) 0.90

Prevention and control of Taenia solium taeniasis/cysticercosis in Peru. Pathog Glob Health (2012) 0.89

Evans blue staining reveals vascular leakage associated with focal areas of host-parasite interaction in brains of pigs infected with Taenia solium. PLoS One (2014) 0.86

Disruption of the blood-brain barrier in pigs naturally infected with Taenia solium, untreated and after anthelmintic treatment. Exp Parasitol (2013) 0.86

An Unusual Presentation of Neurocysticercosis: A Space-Occupying Lesion in the Fourth Ventricle Associated with Progressive Cognitive Decline. Am J Trop Med Hyg (2015) 0.85

Molecular Diagnosis of Human Taenia martis Eye Infection. Am J Trop Med Hyg (2016) 0.84

Post-treatment vascular leakage and inflammatory responses around brain cysts in porcine neurocysticercosis. PLoS Negl Trop Dis (2015) 0.83

Cognitive and surgical outcome in mesial temporal lobe epilepsy associated with hippocampal sclerosis plus neurocysticercosis: a cohort study. PLoS One (2013) 0.83

Enhanced steroid dosing reduces seizures during antiparasitic treatment for cysticercosis and early after. Epilepsia (2014) 0.81

Neurocysticercosis in immigrant populations. J Travel Med (2012) 0.81

Quantitative screening for anticestode drugs based on changes in baseline enzyme secretion by Taenia crassiceps. Antimicrob Agents Chemother (2012) 0.81

Inflammation Caused by Praziquantel Treatment Depends on the Location of the Taenia solium Cysticercus in Porcine Neurocysticercosis. PLoS Negl Trop Dis (2015) 0.80

Current status and future perspectives on the medical treatment of neurocysticercosis. Pathog Glob Health (2012) 0.80

Managing neurocysticercosis: challenges and solutions. Int J Gen Med (2015) 0.79

Feasibility of a lateral flow test for neurocysticercosis using novel up-converting nanomaterials and a lightweight strip analyzer. PLoS Negl Trop Dis (2014) 0.79

Further characterization of Tsol-p27 as a diagnostic antigen in sub-Saharan Africa. Exp Parasitol (2013) 0.77

Patient heal thyself: modeling and treating neurological disorders using patient-derived stem cells. Exp Biol Med (Maywood) (2013) 0.76

Third-ventricular neurocysticercosis: hydraulic maneuvers facilitating endoscopic resection. Childs Nerv Syst (2013) 0.75

Radiological evolution of porcine neurocysticercosis after combined antiparasitic treatment with praziquantel and albendazole. PLoS Negl Trop Dis (2017) 0.75

An anecdotal case of cysticercus of axillary lymph node in a patient with metastatic breast carcinoma. Trop Parasitol (2014) 0.75

In vitro analysis of albendazole sulfoxide enantiomers shows that (+)-(R)-albendazole sulfoxide is the active enantiomer against Taenia solium. Antimicrob Agents Chemother (2012) 0.75

Rising trends of neurocysticercosis: A serological report from tertiary-care hospital in South India. Trop Parasitol (2016) 0.75

Serodiagnosis of human neurocysticercosis using antigenic components of Taenia solium metacestodes derived from the unbound fraction from jacalin affinity chromatography. Mem Inst Oswaldo Cruz (2013) 0.75

Effect of nitazoxanide on albendazole pharmacokinetics in cerebrospinal fluid and plasma in rats. Saudi Pharm J (2016) 0.75

Anti-Taenia solium monoclonal antibodies for the detection of parasite antigens in body fluids from patients with neurocysticercosis. Exp Parasitol (2016) 0.75

Human cysticercosis (Taenia solium). Trop Parasitol (2013) 0.75

Spatiotemporal Expression Patterns and Antibody Reactivity of Taeniidae Endophilin B1. J Clin Microbiol (2016) 0.75

Mixed cestode infection: an incidental association in an immunocompetent person. BMJ Case Rep (2012) 0.75

Occasional resolution of multiple parenchymal brain calcifications in patients with neurocysticercosis. Neurol Clin Pract (2015) 0.75

Asymptomatic Giant Intraventricular Cysticercosis: A Case Report. Hawaii J Med Public Health (2016) 0.75

A Comparative Study of Peripheral Immune Responses to Taenia solium in Individuals with Parenchymal and Subarachnoid Neurocysticercosis. PLoS Negl Trop Dis (2015) 0.75

MicroRNAs in Taenia solium Neurocysticercosis: Insights as Promising Agents in Host-Parasite Interaction and Their Potential as Biomarkers. Front Microbiol (2017) 0.75

Infections of the Central Nervous System in Returning Travelers and Immigrants. Curr Infect Dis Rep (2017) 0.75

A Stratified Analysis of Clinical Manifestations and Different Diagnostic Methods of Neurocysticercosis-Suspected Tamilian Population Residing in and Around Puducherry. J Clin Diagn Res (2017) 0.75

Articles cited by this

(truncated to the top 100)

Proposed diagnostic criteria for neurocysticercosis. Neurology (2001) 9.15

A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med (2004) 5.75

Neurocysticercosis: updated concepts about an old disease. Lancet Neurol (2005) 5.37

Neurocysticercosis in an Orthodox Jewish community in New York City. N Engl J Med (1992) 3.86

Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev (2002) 3.37

Imaging findings in neurocysticercosis. Acta Trop (2003) 3.19

Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study. Lancet Neurol (2008) 3.04

Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology (1992) 2.89

The racemose form of cerebral cysticercosis. Brain (1952) 2.84

The course of seizures after treatment for cerebral cysticercosis. N Engl J Med (1992) 2.77

A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy. PLoS Negl Trop Dis (2010) 2.67

Cognitive impairment and dementia in neurocysticercosis: a cross-sectional controlled study. Neurology (2010) 2.66

Calcific neurocysticercosis and epileptogenesis. Neurology (2004) 2.57

Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel. Ann Intern Med (2006) 2.42

Treatment of neurocysticercosis: current status and future research needs. Neurology (2006) 2.41

Is the course of neurocysticercosis modified by treatment with antihelminthic agents? Arch Intern Med (1995) 2.33

Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial. J Neurol Neurosurg Psychiatry (2008) 2.22

Detection of Taenia solium antigens and anti-T. solium antibodies in paired serum and cerebrospinal fluid samples from patients with intraparenchymal or extraparenchymal neurocysticercosis. J Infect Dis (2009) 2.06

Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru. Neurology (2005) 2.04

Taenia solium taeniosis/cysticercosis in Asia: epidemiology, impact and issues. Acta Trop (2003) 2.03

Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis. J Neurol (1990) 2.02

Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis. J Infect Dis (1991) 1.95

Clinical manifestations associated with neurocysticercosis: a systematic review. PLoS Negl Trop Dis (2011) 1.87

Prevalence, incidence, and etiology of epilepsies in rural Honduras: the Salamá Study. Epilepsia (2005) 1.77

Toll-like receptor 4 polymorphism and its association with symptomatic neurocysticercosis. J Infect Dis (2010) 1.76

Relationship between epilepsy and tropical diseases. Commission on Tropical Diseases of the International League Against Epilepsy. Epilepsia (1994) 1.75

Epilepsy and neurocysticercosis in Atahualpa: a door-to-door survey in rural coastal Ecuador. Epilepsia (2005) 1.65

Neurocysticercosis: a review of current status and management. J Clin Neurosci (2009) 1.62

Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts. N Engl J Med (2001) 1.56

Taenia solium cysticercosis hotspots surrounding tapeworm carriers: clustering on human seroprevalence but not on seizures. PLoS Negl Trop Dis (2009) 1.55

Immunodiagnosis of human cysticercosis (Taenia solium): a field comparison of an antibody-enzyme-linked immunosorbent assay (ELISA), an antigen-ELISA, and an enzyme-linked immunoelectrotransfer blot (EITB) assay in Peru. The Cysticercosis Working Group in Peru (CWG). Am J Trop Med Hyg (1992) 1.53

Extraparenchymal neurocysticercosis: report of five cases and review of management. Clin Infect Dis (1992) 1.50

Calcified cysticerci provoke perilesional edema and seizures. Clin Infect Dis (2001) 1.50

Edema associated with calcified lesions in neurocysticercosis. Neurology (1999) 1.48

Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: a randomized, placebo-controlled, double blind trial. Pediatr Infect Dis J (1998) 1.46

Cerebral cysticercosis: documentation of natural history with CT. Radiology (1989) 1.45

Combination therapy with albendazole and praziquantel versus albendazole alone in children with seizures and single lesion neurocysticercosis: a randomized, placebo-controlled double blind trial. Pediatr Infect Dis J (2009) 1.45

Medical treatment of cysticercosis--effective. Arch Neurol (1995) 1.44

Endoscopic management of cysticercal cysts within the lateral and third ventricles. J Neurosurg (2000) 1.44

Surgical management of neurocysticercosis. Int J Surg (2010) 1.44

Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and intraventricular cysticercosis. Neurology (2005) 1.43

Differentiating solitary small cysticercus granulomas and tuberculomas in patients with epilepsy. Clinical and computerized tomographic criteria. J Neurosurg (1993) 1.40

A diagnostic and therapeutic scheme for a solitary cysticercus granuloma. Neurology (2010) 1.38

The disease burden of Taenia solium cysticercosis in Cameroon. PLoS Negl Trop Dis (2009) 1.35

Persistent MR contrast enhancement of calcified neurocysticercosis lesions. AJNR Am J Neuroradiol (1998) 1.33

Time-response curve of oxfendazole in the treatment of swine cysticercosis. Am J Trop Med Hyg (1998) 1.33

Public health implications of cysticercosis acquired in the United States. Emerg Infect Dis (2011) 1.31

Validation of diagnostic criteria for solitary cerebral cysticercus granuloma in patients presenting with seizures. Acta Neurol Scand (1997) 1.30

Endoscopic management of hydrocephalus due to neurocysticercosis. Clin Neurol Neurosurg (2009) 1.30

Multiantigen print immunoassay for comparison of diagnostic antigens for Taenia solium cysticercosis and taeniasis. Clin Vaccine Immunol (2009) 1.29

Neurocysticercosis: unraveling the nature of the single cysticercal granuloma. Neurology (2010) 1.27

Epilepsy and neurocysticercosis in rural Tanzania-An imaging study. Epilepsia (2008) 1.26

Zoonotic larval cestode infections: neglected, neglected tropical diseases? PLoS Negl Trop Dis (2009) 1.26

Short course of prednisolone in Indian patients with solitary cysticercus granuloma and new-onset seizures. Epilepsia (2003) 1.24

Subarachnoidal and intraventricular human neurocysticercosis: application of an antigen detection assay for the diagnosis and follow-up. Trop Med Int Health (2006) 1.23

Neurocysticercosis in Houston, Texas: an update. Medicine (Baltimore) (2011) 1.19

Albendazole in single CT ring lesions in epilepsy. Neurology (1994) 1.19

Short report: A calcified Taenia solium granuloma associated with recurrent perilesional edema causing refractory seizures: histopathological features. Am J Trop Med Hyg (2011) 1.15

Use of statewide hospital discharge data to evaluate the economic burden of neurocysticercosis in Los Angeles County (1991-2008). Am J Trop Med Hyg (2010) 1.15

Epidemiology of taeniasis and cysticercosis in a Peruvian village. The Cysticercosis Working Group in Peru. Am J Epidemiol (1992) 1.15

Strategies for the elimination of taeniasis/cysticercosis. J Neurol Sci (2007) 1.14

Meta-analysis of the association between cysticercosis and epilepsy in Africa. Epilepsia (2009) 1.13

Serodiagnosis of neurocysticercosis using synthetic 8-kD proteins: comparison of assay formats. Am J Trop Med Hyg (2005) 1.13

Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis. Br J Clin Pharmacol (2011) 1.13

Prevalence of taeniosis among patients with neurocysticercosis is related to severity of infection. TheCysticercosis Working Group in Perú. Neurology (2000) 1.12

Headache and cysticercosis in Ecuador, South America. Headache (1995) 1.12

Hydrocephalus in cerebral cysticercosis. Pathogenic and therapeutic considerations. J Neurosurg (1981) 1.10

Perilesional gliosis and seizure outcome: a study based on magnetization transfer magnetic resonance imaging in patients with neurocysticercosis. Ann Neurol (2000) 1.07

[Therapeutic efficacy of praziquantel, albendazole and a combination of the two drugs in cysticercosis]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi (2003) 1.06

Subarachnoidal Neurocysticercosis non-responsive to cysticidal drugs: a case series. BMC Neurol (2010) 1.05

Development and evaluation of a magnetic immunochromatographic test to detect Taenia solium, which causes taeniasis and neurocysticercosis in humans. Clin Vaccine Immunol (2010) 1.04

Epilepsy and neurocysticercosis: an incidence study in a Peruvian rural population. Neuroepidemiology (2009) 1.04

Endoscopic removal of cysticercal cysts within the fourth ventricle. Technical note. J Neurosurg (1999) 1.02

Taenia solium: molecular cloning and serologic evaluation of 14- and 18-kDa related, diagnostic antigens. J Parasitol (2000) 1.02

Parenchymal neurocysticercosis: follow-up and staging by MRI. Neuroradiology (1997) 0.99

Single-day praziquantel therapy for neurocysticercosis. N Engl J Med (1996) 0.97

Extraparenchymal neurocysticercosis in Albuquerque, New Mexico. J Neuroimaging (2011) 0.96

Methotrexate as a corticosteroid-sparing agent in complicated neurocysticercosis. Clin Infect Dis (2007) 0.96

Albendazole-praziquantel interaction in healthy volunteers: kinetic disposition, metabolism and enantioselectivity. Br J Clin Pharmacol (2011) 0.94

Severe cysticercal meningitis: clinical and imaging characteristics. Am J Trop Med Hyg (2010) 0.94

Epilepsy and neurocysticercosis in sub-Saharan Africa. Wien Klin Wochenschr (2009) 0.93

Porcine antibody responses to taenia solium antigens rGp50 and sTs18var1. Am J Trop Med Hyg (2004) 0.92

Magnetisation transfer magnetic resonance imaging demonstration of perilesional gliosis--relation with epilepsy in treated or healed neurocysticercosis. Lancet (1999) 0.92

Clinical aspects of neurocysticercosis in children. Pediatr Neurol (2000) 0.92

High-dose praziquantel for neurocysticercosis: efficacy and tolerability. Eur Neurol (1990) 0.92

Phenytoin and carbamazepine decreased oral bioavailability of praziquantel. Neurology (1992) 0.91

Failure of one-day praziquantel treatment in patients with multiple neurocysticercosis lesions. Clin Neurol Neurosurg (2001) 0.91

Diagnostic accuracy of rapid enzyme linked immunosorbent assay for the diagnosis of human hydatidosis. Indian J Med Res (1999) 0.87

Severe forms of neurocysticercosis: treatment with albendazole. Arq Neuropsiquiatr (1996) 0.83

Natural history of solitary cerebral cysticercosis cases after albendazole therapy: a longitudinal follow-up study from India. Acta Neurol Scand (2009) 0.82

Comparison of 1 week versus 4 weeks of albendazole therapy in single small enhancing computed tomography lesion. Neurol India (2010) 0.82

Population pharmacokinetics of albendazole in patients with neurocysticercosis. Int J Clin Pharmacol Ther (2009) 0.82

Epidemiologic observations on porcine cysticercosis in a rural community of Michoacan State, Mexico. Vet Parasitol (1992) 0.82

Penetration of praziquantel into cerebrospinal fluid and cysticerci in human cysticercosis. Eur J Clin Pharmacol (1987) 0.81

High-dose praziquantel for neurocysticercosis: serum and CSF concentrations. Acta Neurol Scand (1990) 0.81

[Neurocysticercosis in children: clinical study and follow-up of 112 patients]. Rev Neurol (2006) 0.81

Serological diagnosis and follow-up of severe neurocysticercosis using HP10 antigen detection. Nat Clin Pract Neurol (2007) 0.80

An uncommon cause of seizures in children living in developed countries: neurocysticercosis--a case report. Ital J Pediatr (2011) 0.78

Role of neuroendoscopy in the treatment of large viable cysticerci in the brain parenchyma. Br J Neurosurg (2008) 0.77

MR spectroscopy aids diagnosis in subarachnoid space cysticercosis. Neurol India (2010) 0.77

Articles by these authors

Prevention and control of cystic echinococcosis. Lancet Infect Dis (2007) 3.64

Update on the human broad tapeworm (genus diphyllobothrium), including clinical relevance. Clin Microbiol Rev (2009) 2.78

Species identification after treatment for human taeniasis. Lancet (2004) 2.43

Pulmonary cystic echinococcosis. Curr Opin Pulm Med (2010) 2.20

Neurocysticercosis: A natural human model of epileptogenesis. Epilepsia (2014) 2.11

Detection of Taenia solium antigens and anti-T. solium antibodies in paired serum and cerebrospinal fluid samples from patients with intraparenchymal or extraparenchymal neurocysticercosis. J Infect Dis (2009) 2.06

Epilepsy in poor regions of the world. Lancet (2012) 1.85

Differential diagnosis between cerebral tuberculosis and neurocysticercosis by magnetic resonance spectroscopy. J Comput Assist Tomogr (2005) 1.67

Cystic echinococcosis: chronic, complex, and still neglected. PLoS Negl Trop Dis (2011) 1.61

Ethics review procedures for research in developing countries: a basic presumption of guilt. CMAJ (2004) 1.60

Taenia solium cysticercosis hotspots surrounding tapeworm carriers: clustering on human seroprevalence but not on seizures. PLoS Negl Trop Dis (2009) 1.55

Swine cysticercosis hotspots surrounding Taenia solium tapeworm carriers. Am J Trop Med Hyg (2007) 1.54

Cysticerci-related single parenchymal brain enhancing lesions in non-endemic countries. J Neurol Sci (2012) 1.42

Cysticercosis and neurocysticercosis as pathogens affecting the nervous system. Prog Neurobiol (2009) 1.33

Vaccination of pigs to control human neurocysticercosis. Am J Trop Med Hyg (2005) 1.32

Multiantigen print immunoassay for comparison of diagnostic antigens for Taenia solium cysticercosis and taeniasis. Clin Vaccine Immunol (2009) 1.29

Characterization and cloning of T24, a Taenia solium antigen diagnostic for cysticercosis. Mol Biochem Parasitol (2006) 1.28

Zoonotic larval cestode infections: neglected, neglected tropical diseases? PLoS Negl Trop Dis (2009) 1.26

Diagnosis of cystic echinococcosis, central Peruvian Highlands. Emerg Infect Dis (2008) 1.23

Corticosteroid use in neurocysticercosis. Expert Rev Neurother (2011) 1.17

Development of an enzyme-linked immunoelectrotransfer blot (EITB) assay using two baculovirus expressed recombinant antigens for diagnosis of Taenia solium taeniasis. J Parasitol (2007) 1.15

How many committees does it take to make a project ethical? Lancet (2002) 1.14

Serodiagnosis of neurocysticercosis using synthetic 8-kD proteins: comparison of assay formats. Am J Trop Med Hyg (2005) 1.13

In vitro oncosphere-killing assays to determine immunity to the larvae of Taenia pisiformis, Taenia ovis, Taenia saginata, and Taenia solium. J Parasitol (2006) 1.09

Neurocysticercosis in the infant of a pregnant mother with a tapeworm. Am J Trop Med Hyg (2009) 1.08

Nested PCR for specific diagnosis of Taenia solium taeniasis. J Clin Microbiol (2007) 1.08

Development and evaluation of a magnetic immunochromatographic test to detect Taenia solium, which causes taeniasis and neurocysticercosis in humans. Clin Vaccine Immunol (2010) 1.04

Epilepsy and neurocysticercosis: an incidence study in a Peruvian rural population. Neuroepidemiology (2009) 1.04

Efficacy of diverse antiparasitic treatments for cysticercosis in the pig model. Am J Trop Med Hyg (2012) 1.04

Absence of brain involvement and factors related to positive serology in a prospective series of 61 cases with pulmonary hydatid disease. Am J Trop Med Hyg (2008) 1.04

Seroprevalence of antibodies against Taenia solium cysticerci among refugees resettled in United States. Emerg Infect Dis (2012) 1.03

Characterization, cloning, and expression of two diagnostic antigens for Taenia solium tapeworm infection. J Parasitol (2004) 1.02

Economic burden of neurocysticercosis: results from Peru. Trans R Soc Trop Med Hyg (2007) 0.98

Relationship between serum antibodies and Taenia solium larvae burden in pigs raised in field conditions. PLoS Negl Trop Dis (2013) 0.98

Development of a species-specific coproantigen ELISA for human Taenia solium taeniasis. Am J Trop Med Hyg (2009) 0.97

Taenia solium oncosphere adhesion to intestinal epithelial and Chinese hamster ovary cells in vitro. Infect Immun (2007) 0.97

Prevalence of antibodies to unique Taenia solium oncosphere antigens in taeniasis and human and porcine cysticercosis. Am J Trop Med Hyg (2003) 0.96

Genetic variation in Taenia solium. Parasitol Int (2005) 0.95

Geographic correlation between tapeworm carriers and heavily infected cysticercotic pigs. PLoS Negl Trop Dis (2012) 0.94

Detection of Taenia solium taeniasis coproantigen is an early indicator of treatment failure for taeniasis. Clin Vaccine Immunol (2012) 0.93

Global health training--one way street? Am J Trop Med Hyg (2011) 0.93

Neurocysticercosis-more than a neglected disease. PLoS Negl Trop Dis (2013) 0.93

Porcine antibody responses to taenia solium antigens rGp50 and sTs18var1. Am J Trop Med Hyg (2004) 0.92

Detection of muscle calcifications by thigh CT scan in neurocysticercosis patients. Trans R Soc Trop Med Hyg (2005) 0.91

Neurocysticercosis. Curr Infect Dis Rep (2006) 0.90

Serological diagnosis of lung cystic hydatid disease using the synthetic p176 peptide. Clin Vaccine Immunol (2012) 0.90

Prevention and control of Taenia solium taeniasis/cysticercosis in Peru. Pathog Glob Health (2012) 0.89

Neurocysticercosis. Handb Clin Neurol (2013) 0.89

Screening for cystic echinococcosis in an endemic region of Peru using portable ultrasonography and the enzyme-linked immunoelectrotransfer blot (EITB) assay. Parasitol Res (2005) 0.89

Efficacy of a 3-day course of albendazole treatment in patients with a single neurocysticercosis cyst. Clin Neurol Neurosurg (2005) 0.89

Serologic diagnosis of human Taenia solium cysticercosis by using recombinant and synthetic antigens in QuickELISA™. Am J Trop Med Hyg (2011) 0.89

Hymenolepis nana infection: symptoms and response to nitazoxanide in field conditions. Trans R Soc Trop Med Hyg (2006) 0.88

Human and canine echinococcosis infection in informal, unlicensed abattoirs in Lima, Peru. PLoS Negl Trop Dis (2012) 0.87

Monocyte-astrocyte networks and the regulation of chemokine secretion in neurocysticercosis. J Immunol (2005) 0.87

A simple method for collecting measured whole blood with quantitative recovery of antibody activities for serological surveys. J Immunol Methods (2007) 0.86

Workshop report: Developing an international collaborative research network in neurocysticercosis and epilepsy. Epilepsia (2009) 0.86

Evaluation of nitazoxanide and oxfendazole efficacy against cystic echinococcosis in naturally infected sheep. Am J Trop Med Hyg (2009) 0.85

Tuberculin skin-test reactions are unaffected by the severity of hyperendemic intestinal helminth infections and co-infections. Am J Trop Med Hyg (2010) 0.85

Parasite antigen in serum predicts the presence of viable brain parasites in patients with apparently calcified cysticercosis only. Clin Infect Dis (2013) 0.84

[Neurocysticercosis diagnosis and management in Peru]. Rev Peru Med Exp Salud Publica (2011) 0.83

Recombinant protein- and synthetic peptide-based immunoblot test for diagnosis of neurocysticercosis. J Clin Microbiol (2014) 0.82

Development and evaluation of porcine cysticercosis QuickELISA in Triturus EIA analyzer. J Immunoassay Immunochem (2010) 0.82

Characterization of a novel Taenia solium oncosphere antigen. Mol Biochem Parasitol (2007) 0.82

Neurocysticercosis in immigrant populations. J Travel Med (2012) 0.81

Development of a normal human immunoglobulin G standard curve for enzyme-linked immunosorbent assay: use for comparison of antigen efficacy. J Immunoassay Immunochem (2006) 0.81

Neurocysticercosis uncovered by single-dose albendazole. N Engl J Med (2007) 0.81

Cognitive changes and quality of life in neurocysticercosis: a longitudinal study. PLoS Negl Trop Dis (2012) 0.80

Diphyllobothrium pacificum infection is seldom associated with megaloblastic anemia. Am J Trop Med Hyg (2012) 0.80

Current status and future perspectives on the medical treatment of neurocysticercosis. Pathog Glob Health (2012) 0.80

Simultaneous determination of albendazole metabolites, praziquantel and its metabolite in plasma by high-performance liquid chromatography-electrospray mass spectrometry. J Pharm Biomed Anal (2006) 0.79

Characterization of the carbohydrate components of Taenia solium oncosphere proteins and their role in the antigenicity. Parasitol Res (2013) 0.79

Neurocysticercal antigens stimulate chemokine secretion from human monocytes via an NF-kappaB-dependent pathway. Microbes Infect (2006) 0.79

Mechanisms regulating monocyte CXCL8 secretion in neurocysticercosis and the effect of antiparasitic therapy. J Immunol (2010) 0.78

Neurocysticercosis and the global world. J Neurol (2002) 0.77

Neurocysticercosis in a patient in Canada. CMAJ (2009) 0.77

A truly emerging intestinal parasitosis. Am J Trop Med Hyg (2011) 0.77

Human hydatid disease in Peru is basically restricted to Echinococcus granulosus genotype G1. Am J Trop Med Hyg (2008) 0.76

A novel Taenia solium protein that resembles troponin T proteins. J Parasitol (2009) 0.76

Can Taenia solium latent post-oncospheral stages be found in muscle tissue of cysticercosis-infected pigs (Sus scrofa)? J Parasitol (2006) 0.76

Efficacy of a single oral dose of oxfendazole against Fasciola hepatica in naturally infected sheep. Am J Trop Med Hyg (2012) 0.75

Standardization of a fluorescent-based quantitative adhesion assay to study attachment of Taenia solium oncosphere to epithelial cells in vitro. J Immunol Methods (2011) 0.75

Case 15-2012: Diplopia, headaches, and papilledema. N Engl J Med (2012) 0.75

Seizures, cysticercosis and rural-to-urban migration: the PERU MIGRANT study. Trop Med Int Health (2015) 0.75

[Household factors associated with the presence of human hydatid disease in three rural communities of Junin, Peru]. Rev Peru Med Exp Salud Publica (2011) 0.75

Neurocysticercosis-induced hemichorea. Mov Disord (2006) 0.75

Cysticercosis lesions in basal ganglia are common but clinically silent. Clin Neurol Neurosurg (2002) 0.75

Residual brain calcifications in neurocysticercosis. Am J Trop Med Hyg (2008) 0.75

The tapeworm that turned. Lancet Neurol (2014) 0.75